Manuel Baca

4.8k total citations · 1 hit paper
63 papers, 3.6k citations indexed

About

Manuel Baca is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Manuel Baca has authored 63 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 20 papers in Oncology and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Manuel Baca's work include Monoclonal and Polyclonal Antibodies Research (15 papers), Cytokine Signaling Pathways and Interactions (12 papers) and HIV/AIDS drug development and treatment (7 papers). Manuel Baca is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), Cytokine Signaling Pathways and Interactions (12 papers) and HIV/AIDS drug development and treatment (7 papers). Manuel Baca collaborates with scholars based in Australia, United States and Germany. Manuel Baca's co-authors include Stephen B. H. Kent, Nicos A. Nicola, Douglas J. Hilton, David P. De Souza, Donald Metcalf, Jian‐Guo Zhang, Tracy A. Willson, Luciano Zamboni, Sandra E. Nicholson and Andrew D. Nash and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Manuel Baca

61 papers receiving 3.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation

1999 530 citations Jian‐Guo Zhang, Alison Farley et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Manuel Baca	1.8k	1.4k	1.0k	362	350	63	3.6k
Thomas E. Smithgall	4.3k 2.4×	1.9k 1.3×	1.5k 1.5×	372 1.0×	213 0.6×	175	7.7k
Adrian Whitty	4.2k 2.4×	1.1k 0.7×	1.1k 1.1×	882 2.4×	326 0.9×	78	6.9k
G Steele	2.2k 1.2×	1.6k 1.1×	673 0.7×	428 1.2×	179 0.5×	78	4.9k
Asher Zilberstein	3.8k 2.1×	1.3k 0.9×	1.1k 1.1×	600 1.7×	300 0.9×	68	5.9k
Shiro Akinaga	3.7k 2.1×	1.8k 1.2×	1.7k 1.7×	329 0.9×	77 0.2×	122	6.6k
A L Hubbard	3.7k 2.1×	1000 0.7×	427 0.4×	333 0.9×	238 0.7×	48	5.7k
James M. McDonnell	3.7k 2.1×	787 0.6×	1.5k 1.5×	1.0k 2.8×	201 0.6×	81	6.2k
Brian C. Cunningham	4.4k 2.4×	1.1k 0.7×	936 0.9×	1.5k 4.1×	279 0.8×	47	6.9k
Adrian M. Senderowicz	4.9k 2.7×	3.8k 2.7×	500 0.5×	201 0.6×	172 0.5×	110	8.1k
W. Douglas Fairlie	5.6k 3.2×	1.3k 0.9×	2.4k 2.3×	197 0.5×	546 1.6×	103	8.7k

Countries citing papers authored by Manuel Baca

Since Specialization

Citations

This map shows the geographic impact of Manuel Baca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Baca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Baca more than expected).

Fields of papers citing papers by Manuel Baca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Baca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Baca. The network helps show where Manuel Baca may publish in the future.

Co-authorship network of co-authors of Manuel Baca

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Baca. A scholar is included among the top collaborators of Manuel Baca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Baca. Manuel Baca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lebedeva, Irina V., et al.. (2025). A human antibody specific for SIRPα reprograms macrophages and promotes antibody mediated anti-cancer activity. PLoS ONE. 20(5). e0321169–e0321169.

Lebedeva, Irina V., Lukas M. Carter, Maya Srikanth Graham, et al.. (2025). IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies. Journal of Nuclear Medicine. 66(4). 605–611.

Xu, Linda, Ryan Gilbreth, Manuel Baca, et al.. (2023). Redirecting the specificity of tripartite motif containing-21 scaffolds using a novel discovery and design approach. Journal of Biological Chemistry. 299(12). 105381–105381. 4 indexed citations

Gilbreth, Ryan, et al.. (2018). Crystal structure of the human 4-1BB/4-1BBL complex. Journal of Biological Chemistry. 293(25). 9880–9891. 13 indexed citations

Wendeler, Michaela, Wei Zhao, Christopher Thompson, et al.. (2017). Characterizing the Overall Derivatization of Conjugated Oligomeric Proteins. PDA Journal of Pharmaceutical Science and Technology. 71(2). 115–126. 1 indexed citations

Gilbreth, Ryan, et al.. (2014). Stabilization of the third fibronectin type III domain of human tenascin-C through minimal mutation and rational design. Protein Engineering Design and Selection. 27(10). 411–418. 17 indexed citations

Wang, Lin, Hui Feng, Kristen Lekstrom, et al.. (2013). Multivalent Scaffold Proteins as Superagonists of TRAIL Receptor 2–Induced Apoptosis. Molecular Cancer Therapeutics. 12(7). 1235–1244. 43 indexed citations

Oganesyan, Vaheh, Andrew D. Ferguson, Lin Wang, et al.. (2013). Fibronectin type III domains engineered to bind CD40L: cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of two complexes. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 69(9). 1045–1048. 12 indexed citations

Babon, Jeffrey J., Edward J. McManus, Shenggen Yao, et al.. (2006). The Structure of SOCS3 Reveals the Basis of the Extended SH2 Domain Function and Identifies an Unstructured Insertion That Regulates Stability. Molecular Cell. 22(2). 205–216. 134 indexed citations

10.

Ryan, Daniel, Margaret Sunde, Ann H. Kwan, et al.. (2006). Identification of the Key LMO2-binding Determinants on Ldb1. Journal of Molecular Biology. 359(1). 66–75. 27 indexed citations

11.

Dimitriadis, Evdokia, et al.. (2005). Relaxin and Prostaglandin E₂Regulate Interleukin 11 during Human Endometrial Stromal Cell Decidualization. The Journal of Clinical Endocrinology & Metabolism. 90(6). 3458–3465. 73 indexed citations

12.

Babon, Jeffrey J., Shenggen Yao, David P. De Souza, et al.. (2005). Secondary structure assignment of mouse SOCS3 by NMR defines the domain boundaries and identifies an unstructured insertion in the SH2 domain. FEBS Journal. 272(23). 6120–6130. 42 indexed citations

13.

Fairlie, W. Douglas, Alessandro D. Uboldi, Erinna F. Lee, et al.. (2004). Affinity Maturation of Leukemia Inhibitory Factor and Conversion to Potent Antagonists of Signaling. Journal of Biological Chemistry. 279(3). 2125–2134. 29 indexed citations

14.

Greenhalgh, Christopher J., Donald Metcalf, Anne L. Thaus, et al.. (2002). Biological Evidence That SOCS-2 Can Act Either as an Enhancer or Suppressor of Growth Hormone Signaling. Journal of Biological Chemistry. 277(43). 40181–40184. 143 indexed citations

15.

Nicola, Nicos A., Sandra E. Nicholson, D Metcalf, et al.. (1999). Negative Regulation of Cytokine Signaling by the SOCS Proteins. Cold Spring Harbor Symposia on Quantitative Biology. 64(0). 397–404. 27 indexed citations

16.

Baca, Manuel, et al.. (1997). Antibody Humanization Using Monovalent Phage Display. Journal of Biological Chemistry. 272(16). 10678–10684. 113 indexed citations

17.

Baca, Manuel, et al.. (1995). Is α-tocopherol a reservoir for α-tocopheryl hydroquinone?. Free Radical Biology and Medicine. 19(2). 197–207. 59 indexed citations

18.

Kent, Stephen B. H., Manuel Baca, John H. Elder, et al.. (1995). Breaking the Shackles of the Genetic Code: Engineering Retroviral Proteases Through Total Chemical Synthesis. Advances in experimental medicine and biology. 362. 425–438. 3 indexed citations

19.

Baca, Manuel, et al.. (1994). Complete Chemical Structure of Photoactive Yellow Protein: Novel Thioester-Linked 4-Hydroxycinnamyl Chromophore and Photocycle Chemistry. Biochemistry. 33(48). 14369–14377. 240 indexed citations

20.

Baca, Manuel, Stephen B. H. Kent, & Paul F. Alewood. (1993). Structural engineering of the HIV‐1 protease molecule with a β‐turn mimic of fixed geometry. Protein Science. 2(7). 1085–1091. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact